Cefcapene
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(6R,7R)-3-{[(Aminocarbonyl)oxy]methyl}-7-{(Z)-[2-(2-amino-4-thiazolyl)-1-oxo-2-pentenyl]amino}-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number |
135889-00-8 |
| ATC code | J01DD17 (WHO) |
| PubChem | CID 6436055 |
| ChemSpider |
4940731 |
| UNII |
4D5D3422MW |
| KEGG |
D07638 |
| ChEBI | CHEBI:131729 |
| ChEMBL |
CHEMBL582912 |
| Chemical data | |
| Formula | C17H19N5O6S2 |
| Molar mass | 453.49 g/mol |
| |
| |
| | |
Cefcapene (INN) is a third-generation cephalosporin antibiotic.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Friday, April 15, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
